P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY

Hepatic encephalopathy (HE) is the most common neuropsychiatric syndrome secondary to portal hypertension. It usually responds to medical treatment, but sometimes HE is refractory (RHE) to usual treatment. In some patients it may be important to consider management alternatives. Endovascular therapy...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hepatology 2021-09, Vol.24, p.100403, Article 100403
Main Authors: Muñoz, Claudia, Ramírez, Felipe, Martínez, Nicolás, Palavecino, Patricio, Pavez, Claudia, Urzúa, Alvaro, Cattaneo, Máximo, Roblero, Juan Pablo, Poníachik, Jaime
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 100403
container_title Annals of hepatology
container_volume 24
creator Muñoz, Claudia
Ramírez, Felipe
Martínez, Nicolás
Palavecino, Patricio
Pavez, Claudia
Urzúa, Alvaro
Cattaneo, Máximo
Roblero, Juan Pablo
Poníachik, Jaime
description Hepatic encephalopathy (HE) is the most common neuropsychiatric syndrome secondary to portal hypertension. It usually responds to medical treatment, but sometimes HE is refractory (RHE) to usual treatment. In some patients it may be important to consider management alternatives. Endovascular therapy (ET) could be a therapeutic option in selected cases that is performed with very low frequency and the evidence is scarce. To present our experience in the management of RHE with ET. The pre and post-procedure clinical characteristics of 10 patients with RHE undergoing splenic vein embolization (n: 5) or porto-systemic bypass embolization (n: 5) between 2009-2019 were retrospectively analyzed. 7/10 were men, average age 67 years (62-79), in 70% the cause of cirrhosis was NASH, the Child Pugh average score was B (8 points), (6-11) and MELD-Na was 13 points, (9-20), in 5 patients the ammonia prior to the procedure was 134 mmol / l (range: 90-180, VN
doi_str_mv 10.1016/j.aohep.2021.100403
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3836875601e84e26acf6d1abecbc3865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1665268121001022</els_id><doaj_id>oai_doaj_org_article_3836875601e84e26acf6d1abecbc3865</doaj_id><sourcerecordid>S1665268121001022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2093-d1b5e70e8f36d8f1eef1545aa6baf50aee98f01b2df1a94866dce8e020315da43</originalsourceid><addsrcrecordid>eNp9kM1O6zAQhS0EEuXnCdjkBVL8ExtnwcIKbhOpNFFIEV1ZjjOGVEBQgq503x6XIpasRnN0zqeZg9AVwXOCibjeze3wAh9ziikJCk4wO0IzKnga81TSYzQjQvCYCklO0dk07YKFcUJnyFUxSyP9VOm60OtMR8U6anId3au1Wup7vW6ichHVelGrrCnrbZTrSjVFFu3NVa5WZVjzbcjU5WaZB_mufFQP2Wal6j2oVtX2Ap14-zrB5c88R5uFbrI8XpXLIlOr2FGcsrgjLYcbDNIz0UlPADzhCbdWtNZzbAFS6TFpaeeJTRMpROdAAqaYEd7ZhJ2j4sDtBrszH2P_Zsf_ZrC9-RaG8dnY8bN3r2CYZELecIEJyASosM6LjtgWXOuYFDyw2IHlxmGaRvC_PILNvnOzM9-dm33n5tB5SN0eUhDe_NfDaCbXw7uDrh_BfYY7-j_zX3gbgq8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY</title><source>ScienceDirect®</source><creator>Muñoz, Claudia ; Ramírez, Felipe ; Martínez, Nicolás ; Palavecino, Patricio ; Pavez, Claudia ; Urzúa, Alvaro ; Cattaneo, Máximo ; Roblero, Juan Pablo ; Poníachik, Jaime</creator><creatorcontrib>Muñoz, Claudia ; Ramírez, Felipe ; Martínez, Nicolás ; Palavecino, Patricio ; Pavez, Claudia ; Urzúa, Alvaro ; Cattaneo, Máximo ; Roblero, Juan Pablo ; Poníachik, Jaime</creatorcontrib><description>Hepatic encephalopathy (HE) is the most common neuropsychiatric syndrome secondary to portal hypertension. It usually responds to medical treatment, but sometimes HE is refractory (RHE) to usual treatment. In some patients it may be important to consider management alternatives. Endovascular therapy (ET) could be a therapeutic option in selected cases that is performed with very low frequency and the evidence is scarce. To present our experience in the management of RHE with ET. The pre and post-procedure clinical characteristics of 10 patients with RHE undergoing splenic vein embolization (n: 5) or porto-systemic bypass embolization (n: 5) between 2009-2019 were retrospectively analyzed. 7/10 were men, average age 67 years (62-79), in 70% the cause of cirrhosis was NASH, the Child Pugh average score was B (8 points), (6-11) and MELD-Na was 13 points, (9-20), in 5 patients the ammonia prior to the procedure was 134 mmol / l (range: 90-180, VN &lt;30), the average degree of HE was 2-3 on the scale of West Haven. One week after the procedure, in all patients the grade of EH decreased to 0-1 and the ammonium to 88 mmol / l. At one month, the grade of HE was 0 in all patients and that of ammonia was 83 mmol / l. There were no complications from the procedure. The results obtained confirm that ET in patients with Child B HE and MELD-Na maximum of 20 is a safe and effective procedure, associated with clinical improvement in RHE.</description><identifier>ISSN: 1665-2681</identifier><identifier>EISSN: 2659-5982</identifier><identifier>DOI: 10.1016/j.aohep.2021.100403</identifier><language>eng</language><publisher>Elsevier España, S.L.U</publisher><ispartof>Annals of hepatology, 2021-09, Vol.24, p.100403, Article 100403</ispartof><rights>2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1665268121001022$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3547,27922,27923,45778</link.rule.ids></links><search><creatorcontrib>Muñoz, Claudia</creatorcontrib><creatorcontrib>Ramírez, Felipe</creatorcontrib><creatorcontrib>Martínez, Nicolás</creatorcontrib><creatorcontrib>Palavecino, Patricio</creatorcontrib><creatorcontrib>Pavez, Claudia</creatorcontrib><creatorcontrib>Urzúa, Alvaro</creatorcontrib><creatorcontrib>Cattaneo, Máximo</creatorcontrib><creatorcontrib>Roblero, Juan Pablo</creatorcontrib><creatorcontrib>Poníachik, Jaime</creatorcontrib><title>P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY</title><title>Annals of hepatology</title><description>Hepatic encephalopathy (HE) is the most common neuropsychiatric syndrome secondary to portal hypertension. It usually responds to medical treatment, but sometimes HE is refractory (RHE) to usual treatment. In some patients it may be important to consider management alternatives. Endovascular therapy (ET) could be a therapeutic option in selected cases that is performed with very low frequency and the evidence is scarce. To present our experience in the management of RHE with ET. The pre and post-procedure clinical characteristics of 10 patients with RHE undergoing splenic vein embolization (n: 5) or porto-systemic bypass embolization (n: 5) between 2009-2019 were retrospectively analyzed. 7/10 were men, average age 67 years (62-79), in 70% the cause of cirrhosis was NASH, the Child Pugh average score was B (8 points), (6-11) and MELD-Na was 13 points, (9-20), in 5 patients the ammonia prior to the procedure was 134 mmol / l (range: 90-180, VN &lt;30), the average degree of HE was 2-3 on the scale of West Haven. One week after the procedure, in all patients the grade of EH decreased to 0-1 and the ammonium to 88 mmol / l. At one month, the grade of HE was 0 in all patients and that of ammonia was 83 mmol / l. There were no complications from the procedure. The results obtained confirm that ET in patients with Child B HE and MELD-Na maximum of 20 is a safe and effective procedure, associated with clinical improvement in RHE.</description><issn>1665-2681</issn><issn>2659-5982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kM1O6zAQhS0EEuXnCdjkBVL8ExtnwcIKbhOpNFFIEV1ZjjOGVEBQgq503x6XIpasRnN0zqeZg9AVwXOCibjeze3wAh9ziikJCk4wO0IzKnga81TSYzQjQvCYCklO0dk07YKFcUJnyFUxSyP9VOm60OtMR8U6anId3au1Wup7vW6ichHVelGrrCnrbZTrSjVFFu3NVa5WZVjzbcjU5WaZB_mufFQP2Wal6j2oVtX2Ap14-zrB5c88R5uFbrI8XpXLIlOr2FGcsrgjLYcbDNIz0UlPADzhCbdWtNZzbAFS6TFpaeeJTRMpROdAAqaYEd7ZhJ2j4sDtBrszH2P_Zsf_ZrC9-RaG8dnY8bN3r2CYZELecIEJyASosM6LjtgWXOuYFDyw2IHlxmGaRvC_PILNvnOzM9-dm33n5tB5SN0eUhDe_NfDaCbXw7uDrh_BfYY7-j_zX3gbgq8</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Muñoz, Claudia</creator><creator>Ramírez, Felipe</creator><creator>Martínez, Nicolás</creator><creator>Palavecino, Patricio</creator><creator>Pavez, Claudia</creator><creator>Urzúa, Alvaro</creator><creator>Cattaneo, Máximo</creator><creator>Roblero, Juan Pablo</creator><creator>Poníachik, Jaime</creator><general>Elsevier España, S.L.U</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202109</creationdate><title>P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY</title><author>Muñoz, Claudia ; Ramírez, Felipe ; Martínez, Nicolás ; Palavecino, Patricio ; Pavez, Claudia ; Urzúa, Alvaro ; Cattaneo, Máximo ; Roblero, Juan Pablo ; Poníachik, Jaime</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2093-d1b5e70e8f36d8f1eef1545aa6baf50aee98f01b2df1a94866dce8e020315da43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muñoz, Claudia</creatorcontrib><creatorcontrib>Ramírez, Felipe</creatorcontrib><creatorcontrib>Martínez, Nicolás</creatorcontrib><creatorcontrib>Palavecino, Patricio</creatorcontrib><creatorcontrib>Pavez, Claudia</creatorcontrib><creatorcontrib>Urzúa, Alvaro</creatorcontrib><creatorcontrib>Cattaneo, Máximo</creatorcontrib><creatorcontrib>Roblero, Juan Pablo</creatorcontrib><creatorcontrib>Poníachik, Jaime</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Directory of Open Access Journals</collection><jtitle>Annals of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muñoz, Claudia</au><au>Ramírez, Felipe</au><au>Martínez, Nicolás</au><au>Palavecino, Patricio</au><au>Pavez, Claudia</au><au>Urzúa, Alvaro</au><au>Cattaneo, Máximo</au><au>Roblero, Juan Pablo</au><au>Poníachik, Jaime</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY</atitle><jtitle>Annals of hepatology</jtitle><date>2021-09</date><risdate>2021</risdate><volume>24</volume><spage>100403</spage><pages>100403-</pages><artnum>100403</artnum><issn>1665-2681</issn><eissn>2659-5982</eissn><abstract>Hepatic encephalopathy (HE) is the most common neuropsychiatric syndrome secondary to portal hypertension. It usually responds to medical treatment, but sometimes HE is refractory (RHE) to usual treatment. In some patients it may be important to consider management alternatives. Endovascular therapy (ET) could be a therapeutic option in selected cases that is performed with very low frequency and the evidence is scarce. To present our experience in the management of RHE with ET. The pre and post-procedure clinical characteristics of 10 patients with RHE undergoing splenic vein embolization (n: 5) or porto-systemic bypass embolization (n: 5) between 2009-2019 were retrospectively analyzed. 7/10 were men, average age 67 years (62-79), in 70% the cause of cirrhosis was NASH, the Child Pugh average score was B (8 points), (6-11) and MELD-Na was 13 points, (9-20), in 5 patients the ammonia prior to the procedure was 134 mmol / l (range: 90-180, VN &lt;30), the average degree of HE was 2-3 on the scale of West Haven. One week after the procedure, in all patients the grade of EH decreased to 0-1 and the ammonium to 88 mmol / l. At one month, the grade of HE was 0 in all patients and that of ammonia was 83 mmol / l. There were no complications from the procedure. The results obtained confirm that ET in patients with Child B HE and MELD-Na maximum of 20 is a safe and effective procedure, associated with clinical improvement in RHE.</abstract><pub>Elsevier España, S.L.U</pub><doi>10.1016/j.aohep.2021.100403</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1665-2681
ispartof Annals of hepatology, 2021-09, Vol.24, p.100403, Article 100403
issn 1665-2681
2659-5982
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3836875601e84e26acf6d1abecbc3865
source ScienceDirect®
title P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A55%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P-39%20EXPERIENCE%20IN%20THE%20MANAGEMENT%20OF%20REFRACTORY%20HEPATIC%20ENCEPHALOPATHY%20THROUGH%20ENDOVASCULAR%20THERAPY&rft.jtitle=Annals%20of%20hepatology&rft.au=Mu%C3%B1oz,%20Claudia&rft.date=2021-09&rft.volume=24&rft.spage=100403&rft.pages=100403-&rft.artnum=100403&rft.issn=1665-2681&rft.eissn=2659-5982&rft_id=info:doi/10.1016/j.aohep.2021.100403&rft_dat=%3Celsevier_doaj_%3ES1665268121001022%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2093-d1b5e70e8f36d8f1eef1545aa6baf50aee98f01b2df1a94866dce8e020315da43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true